Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 25, 2023
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
Brian Cheng Maintained (BCAB) at Buy with Decreased Target to $14 on, Sep 25th, 2023
Brian Cheng of JP Morgan, Maintained "BioAtla, Inc." (BCAB) at Buy with Decreased Target from $17 to $14 on, Sep 25th, 2023.
Brian has made no other calls on BCAB in the last 4 months.
There are 3 other peers that have a rating on BCAB. Out of the 3 peers that are also analyzing BCAB, 0 agree with Brian's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Brian
- Arthur He of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $17 on, Wednesday, August 2nd, 2023
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $12 on, Wednesday, August 2nd, 2023
- Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $25 on, Wednesday, August 2nd, 2023
